Detalles de la búsqueda
1.
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamide.
Immunol Cell Biol
; 101(7): 639-656, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37191045
2.
Post-transplant cyclophosphamide limits reactive donor T cells and delays the development of graft-versus-host disease in a humanized mouse model.
Immunology
; 164(2): 332-347, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34021907
3.
P2X7 receptor antagonism increases regulatory T cells and reduces clinical and histological graft-versus-host disease in a humanised mouse model.
Clin Sci (Lond)
; 135(3): 495-513, 2021 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33463682
4.
Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease.
Int J Mol Sci
; 22(15)2021 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34361109
5.
A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model.
Immunol Cell Biol
; 98(5): 397-410, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32181525
6.
Increased P2X7 expression in the gastrointestinal tract and skin in a humanised mouse model of graft-versus-host disease.
Clin Sci (Lond)
; 134(2): 207-223, 2020 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31934722
7.
Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease.
Methods Mol Biol
; 2510: 315-340, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776334
8.
Increased splenic human CD4+:CD8+ T cell ratios, serum human interferon-γ and intestinal human interleukin-17 are associated with clinical graft-versus-host disease in humanized mice.
Transpl Immunol
; 54: 38-46, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30743002
Resultados
1 -
8
de 8
1
Próxima >
>>